Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1881 1
1955 1
1956 1
1957 1
1958 1
1960 1
1962 2
1963 5
1964 3
1965 7
1966 7
1967 3
1968 5
1969 5
1970 3
1971 1
1972 3
1973 7
1974 9
1975 8
1976 1
1977 4
1978 11
1979 11
1980 12
1981 12
1982 13
1983 16
1984 23
1985 14
1986 13
1987 14
1988 16
1989 28
1990 19
1991 15
1992 16
1993 12
1994 14
1995 14
1996 15
1997 10
1998 8
1999 18
2000 11
2001 8
2002 14
2003 9
2004 18
2005 19
2006 20
2007 18
2008 26
2009 39
2010 39
2011 49
2012 56
2013 45
2014 49
2015 45
2016 38
2017 48
2018 39
2019 53
2020 49
2021 51
2022 49
2023 52
2024 57
2025 41

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,224 results

Results by year

Filters applied: . Clear all
Page 1
Management of Crohn Disease: A Review.
Cushing K, Higgins PDR. Cushing K, et al. JAMA. 2021 Jan 5;325(1):69-80. doi: 10.1001/jama.2020.18936. JAMA. 2021. PMID: 33399844 Free PMC article. Review.
A global view on carbapenem-resistant Acinetobacter baumannii.
Müller C, Reuter S, Wille J, Xanthopoulou K, Stefanik D, Grundmann H, Higgins PG, Seifert H. Müller C, et al. mBio. 2023 Dec 19;14(6):e0226023. doi: 10.1128/mbio.02260-23. Epub 2023 Oct 26. mBio. 2023. PMID: 37882512 Free PMC article.
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials.
Danese S, Vermeire S, Zhou W, Pangan AL, Siffledeen J, Greenbloom S, Hébuterne X, D'Haens G, Nakase H, Panés J, Higgins PDR, Juillerat P, Lindsay JO, Loftus EV Jr, Sandborn WJ, Reinisch W, Chen MH, Sanchez Gonzalez Y, Huang B, Xie W, Liu J, Weinreich MA, Panaccione R. Danese S, et al. Lancet. 2022 Jun 4;399(10341):2113-2128. doi: 10.1016/S0140-6736(22)00581-5. Epub 2022 May 26. Lancet. 2022. PMID: 35644166 Clinical Trial.
Charting human development using a multi-endodermal organ atlas and organoid models.
Yu Q, Kilik U, Holloway EM, Tsai YH, Harmel C, Wu A, Wu JH, Czerwinski M, Childs CJ, He Z, Capeling MM, Huang S, Glass IA, Higgins PDR, Treutlein B, Spence JR, Camp JG. Yu Q, et al. Cell. 2021 Jun 10;184(12):3281-3298.e22. doi: 10.1016/j.cell.2021.04.028. Epub 2021 May 20. Cell. 2021. PMID: 34019796 Free PMC article.
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
Brown DM, Wykoff CC, Boyer D, Heier JS, Clark WL, Emanuelli A, Higgins PM, Singer M, Weinreich DM, Yancopoulos GD, Berliner AJ, Chu K, Reed K, Cheng Y, Vitti R. Brown DM, et al. JAMA Ophthalmol. 2021 Sep 1;139(9):946-955. doi: 10.1001/jamaophthalmol.2021.2809. JAMA Ophthalmol. 2021. PMID: 34351414 Free PMC article. Clinical Trial.
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.
Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, Brouwers FP, Asselbergs FW, van Gilst W, Anderssen SA, Grobbee DE, Kastelein JJP, Visseren FLJ, Ntaios G, Hatzitolios AI, Savopoulos C, Nieuwkerk PT, Stroes E, Walters M, Higgins P, Dawson J, Gresele P, Guglielmini G, Migliacci R, Ezhov M, Safarova M, Balakhonova T, Sato E, Amaha M, Nakamura T, Kapellas K, Jamieson LM, Skilton M, Blumenthal JA, Hinderliter A, Sherwood A, Smith PJ, van Agtmael MA, Reiss P, van Vonderen MGA, Kiechl S, Klingenschmid G, Sitzer M, Stehouwer CDA, Uthoff H, Zou ZY, Cunha AR, Neves MF, Witham MD, Park HW, Lee MS, Bae JH, Bernal E, Wachtell K, Kjeldsen SE, Olsen MH, Preiss D, Sattar N, Beishuizen E, Huisman MV, Espeland MA, Schmidt C, Agewall S, Ok E, Aşçi G, de Groot E, Grooteman MPC, Blankestijn PJ, Bots ML, Sweeting MJ, Thompson SG, Lorenz MW; PROG-IMT and the Proof-ATHERO Study Groups. Willeit P, et al. Circulation. 2020 Aug 18;142(7):621-642. doi: 10.1161/CIRCULATIONAHA.120.046361. Epub 2020 Jun 17. Circulation. 2020. PMID: 32546049 Free PMC article.
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.
Berinstein JA, Karl T, Patel A, Dolinger M, Barrett TA, Ahmed W, Click B, Steiner CA, Dulaney D, Levine J, Hassan SA, Perry C, Flomenhoft D, Ungaro RC, Berinstein EM, Sheehan J, Cohen-Mekelburg S, Regal RE, Stidham RW, Bishu S, Colombel JF, Higgins PDR. Berinstein JA, et al. Am J Gastroenterol. 2024 Mar 27:10.14309/ajg.0000000000002674. doi: 10.14309/ajg.0000000000002674. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38275248 Free PMC article.
Fibroblast lipid metabolism through ACSL4 regulates epithelial sensitivity to ferroptosis in IBD.
Huang W, Zhang Y, Das NK, Solanki S, Jain C, El-Derany MO, Koo I, Bell HN, Aabed N, Singhal R, Castillo C, Buscher K, Ying Y, Dimitroff J, Sharma A, Shi J, Hogan SP, Dame MK, Higgins PDR, Colacino JA, Oh TG, Spence JR, Patterson AD, Greenberg AS, Greenson JK, Nusrat A, Shah YM. Huang W, et al. Nat Metab. 2025 Jul;7(7):1358-1374. doi: 10.1038/s42255-025-01313-x. Epub 2025 Jun 26. Nat Metab. 2025. PMID: 40571769
1,224 results